Onkologie. 2009:3(3):181-189

Subsequent primary neoplasms in 125 262 cancer patients in the Czech Republic 1976-2005

Edvard Geryk2, Petr Dítě1,2, Miloš Pešek3, Jiří Kozel4
1 III. interní klinika gastroenterologická, FN Brno-Bohunice
2 Fakultní nemocnice Brno Bohunice
3 Fakultní nemocnice Plzeň
4 PřF MU Brno

During 1976–2005 the Czech Cancer Registry registered 1.486,984 neoplasms dg. C00–D48, of which in 125,262 (8.4 %) cancer patients

were diagnosed 165,050 (11.1 %) subsequent neoplasms. There were treated 81.7 % patients of duplicities and 18.3 % of multiplicities. There

were higher duplicities in women and on the contrary higher multiplicities in men. The age groups 50–69 years contributed most to 52.4 %

primary diseases in men and 47.8 % in women. Their most frequent occurence were in regions Northern and Southern Moravia and Prague.

The most frequent of primary diseases were tumors of skin 42.8 %, digestive 11.8 %, urinary 6.8 % and respiratory system 4.8 %, breast

8.4 %, female 7 % and male genital tract 4.2 %. The average length between the primary and subsequent diseases was 6 years in men and

6.6 years in women. During the first year after primary disease occured 15,602 (17.4 %) subsequent neoplasms in men and 11,689 (15.5 %)

in women. The proportion of synchronous and metachronous diseases was 1:4.8 in men and 1:5.4 in women. From 125,262 patients died

84,101 (29.9 % men, 27.9 % women) and survived 41,161 (12.2 % men, 16.5 % women) as of 17. 10. 2007. The numbers of died from primary

neoplasms increased till 1994–1995 and survived till 2002, then decreased. From the presented data follows the necessity of screening

programmes and importace of sufficient long permanent medical surveillance, especially in view of multiple primary and subsequent solid

tumors and the most frequent cancers of skin. The broad public information and education of the first cancer symptoms and improving of

life-style is not yet sufficient both for healthy population and for 395,547 treated patients with cancers in 2005.

Keywords: multiple neoplasms, time, age and space distribution.

Published: June 15, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geryk E, Dítě P, Pešek M, Kozel J. Subsequent primary neoplasms in 125 262 cancer patients in the Czech Republic 1976-2005. Onkologie. 2009;3(3):181-189.
Download citation

References

  1. Konečný M a kol. Prevalence nádorů v České republice, 1989-2005-2015. PřF MU Brno, 2008; 69 s. + CD, ISBN 978-80-903255-2-4.
  2. Billroth CAT. Die allgemeine chirurgische pathologie und therapie. Berlin, Reimer G, 1889; 908 p.
  3. Boice JD Jr, et al. Multiple primary cancers in Connecticut and Denmark. Natl. Canc. Inst. Monogr., 1985; 68 p.
  4. Dong C, et al. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int. J. Canc., 2001; 93(2): 155-161. Go to original source... Go to PubMed...
  5. Daly MB, et al. Breast cancer. In: Neugut AI, et al. Multiple primary cancers. Philadelphia, Lippincott Williams-Wilkins, 1999; 303-317.
  6. Mellemkjaer L, et al. Risk of second cancer among women with breast cancer. Int. J. Canc., 2006; 118(9): 2285-2292. Go to original source... Go to PubMed...
  7. Ewertz M, et al. Second cancer following cancer of the female breast in Denmark, 1943-1980. Natl. Canc. Inst. Monogr., 1985; 68: 325-329.
  8. Ries LAG, et al. SEER cancer statistics review, 1975-2003. Bethesda, National Canc. Inst., http://seer.cancer.gov/csr/1975-2003, based on Nov. 2005 SEER data submission, 2006.
  9. Mariotto A. Personal communication. Div. of Canc. Control and Population Sci., NCI. In: Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973-2000. NCI, NIH Publ. No. 05-5302, Bethesda MD, 2006; 1.
  10. Fraumeni J. Jr. Overall risk of subsequent cancers. In: Curtis RE, et al. New malignancies among cancer survivors: SEER cancer registries 1973-2000. NCI, NIH Publ. No. 05-5302, Bethesda MD, 2006; 3.
  11. CDC-LAF: A national action plan for cancer survivorship: Advancing public health strategies. Centers for Disease Control and Perevention, Lance Armstrong Foundation, Atlanta GA, 2004.
  12. Geryk E a kol. Výskyt vícečetných nádorů spojených s karcinomem prsu na jižní Moravě v letech 1976-1996. In: Zhoubné novotvary-jižní Morava 1997. MOÚ Brno, 1998; 35-36. ISBN 80-902266-3-9.
  13. Vítová V. Způsob určování vícečetných malignit v České republice. Klin. onkol., 2002; 15(3): 106.
  14. Geryk E a kol. Vícečetné zhoubné novotvary - ukazatel zdraví a nákladů péče v onkologii. Zdravotnictví v ČR, 2008; 2(11): 50-55.
  15. ÚZIS: Závazné pokyny NZIS k obsahu datové struktury Národního onkologického registru, verze 051-20060101/2, http://www.uzis.cz.
  16. Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int. J. Urol. 2005; 12(8): 709-716. Go to original source... Go to PubMed...
  17. Schrijvers D, et al. Handbook of cancer prevention, ESMO Informa - healthcare, 2008; pp. 67-103, United Kingdom, ISBN 10-1-41539085.
  18. Do KA, et al. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer, 2004; 101(12): 2837-2842. Go to original source... Go to PubMed...
  19. Vítová V a kol. Kolorektální karcinom jako nádorová duplicita. In: Vyzula R a kol. Rakovina tlustého střeva a konečníku - vybrané kapitoly. 2008; 55-61 s, ISBN 978-86-7345-140-0.
  20. Geryk E a kol. Vybrané charakteristiky 165.050 následných zhoubných novotvarů u onkologicky přežívajících v České republice. Onkologie, 2009; v tisku.
  21. Key TJ, et al. Diet, nutrition and the prevention of cancer. Publ. Health Nutr. 2004; 7(1A): 187-200. Go to original source... Go to PubMed...
  22. Boffetta P, et al. The burden of cancer attributable to alcohol drinking. Int. J. Canc. 2006; 119(4): 884-887. Go to original source... Go to PubMed...
  23. ÚZIS: Novotvary 2005 ČR. Zdravotnická statistika, ÚZIS ČR, Praha, 243-245 s, ISBN 978-80-7280-723-9.
  24. Garber JE, et al. Hereditary cancer predisposition syndromes. J. Clin. Oncol. 2005; 23(2): 276-292. Go to original source... Go to PubMed...
  25. Geryk E a kol. Karcinom prsu a následné primární zhoubné novotvary v České republice 1976-2005. Onkologie 2009; 3(1): 46-53.
  26. Curtis RE, et al. New malignancies following breast cancer. In: New malignancies among cancer survivors: SEER cancer registries 1973-2000. NCI, NIH Publ. No. 05-5302, Bethesda MD, 2006; pp. 181-205.
  27. Pinto BM, et al. Health behaviors during and after a cancer diagnosis. Cancer, 2005; 104(Suppl 11): 2614-2623. Go to original source... Go to PubMed...
  28. van Leeuwen FE, et al. Second cancers. In: DeVita VT Jr, et al. Cancer: Principles and practice of oncology, 7th ed. Philadelphia, Lippincott Williams-Wilkins, 2005; pp. 2575-2602.
  29. Travis LB, et al. Cancer survivorship-genetic susceptibility and second primary cancers: research strategies and recimmendations. J. Natl. Canc. Inst., 2006; 98(1): 1-11. Go to original source... Go to PubMed...
  30. Petruželka L. Od onkologického nihilismu k aktivní léčbě pokročilých nádorových onemocnění. Sborník XIII. dny prof. V. Staška, Praha 2009; 4-5, ISBN 978-80-254-1284-8.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.